TOKYO, Apr 24, 2018 - (JCN Newswire) - Showa Denko (SDK) has entered into an agreement with Astellas Pharma Inc. supporting its research on the practical applications of MucoRice-CTB, a rice-based oral vaccine, to be carried out with the Institute of Medical Science, the University of Tokyo, Chiba University and Asahi Kogyosha.

SDK will be...